1-20 of 410
chile
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutational landscape of gray zone lymphoma

Clémentine Sarkozy, Stacy S. Hung, Elizabeth A. Chavez, Gerben Duns, Katsuyoshi Takata, Lauren C. Chong, Tomohiro Aoki, Aixiang Jiang, Tomoko Miyata-Takata, Adèle Telenius, Graham W. Slack, Thierry Jo Molina, Susana Ben-Neriah, Pedro Farinha, Peggy Dartigues, Diane Damotte, Anja Mottok, Gilles A. Salles, Rene-Olivier Casasnovas, Kerry J. Savage, Camille Laurent, David W. Scott, Alexandra Traverse-Glehen, Christian Steidl
Journal: Blood
Blood (2021) 137 (13): 1765–1776.
DOI: https://doi.org/10.1182/blood.2020007507
Published: 2021
Includes: Supplemental data
Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Gabriel K. Griffin, Jason L. Weirather, Margaretha G. M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini, Bjoern Chapuy, Michael H. Rosenthal, Jie Xu, Benjamin J. Chen, Aliyah R. Sohani, Scott B. Lovitch, Jeremy S. Abramson, Jeffrey J. Ishizuka, Austin I. Kim, Caron A. Jacobson, Ann S. LaCasce, Christopher D. Fletcher, Donna Neuberg, Gordon J. Freeman, F. Stephen Hodi, Kyle Wright, Azra H. Ligon, Eric D. Jacobsen, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
Journal: Blood
Blood (2021) 137 (10): 1353–1364.
DOI: https://doi.org/10.1182/blood.2020006464
Published: 2021
Includes: Supplemental data
Journal Articles

Immune escape mechanisms for TCRLBCL

Wing C. Chan
Journal: Blood
Blood (2021) 137 (10): 1274–1276.
DOI: https://doi.org/10.1182/blood.2020008766
Published: 2021
Journal Articles

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Clinical Trials & Observations
Pamela B. Allen, Hatice Savas, Andrew M. Evens, Ranjana H. Advani, Brett Palmer, Barbara Pro, Reem Karmali, Eric Mou, Jeffrey Bearden, Gary Dillehay, Robert A. Bayer, Robert M. Eisner, Joan S. Chmiel, Kaitlyn O’Shea, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2021) 137 (10): 1318–1326.
DOI: https://doi.org/10.1182/blood.2020007400
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Kirsty Wienand, Atanas Kamburov, Gabriel K. Griffin, Pei-Hsuan Chen, Ana Lako, Robert A. Redd, Claire M. Cote, Matthew D. Ducar, Aaron R. Thorner, Scott J. Rodig, Gad Getz, Margaret A. Shipp
Journal: Blood
Blood (2019) 134 (26): 2369–2382.
DOI: https://doi.org/10.1182/blood.2019002067
Published: 2019
Includes: Supplemental data
Journal Articles

The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4–positive T cells that are PD-1–negative

Sanjay S. Patel, Jason L. Weirather, Mikel Lipschitz, Ana Lako, Pei-Hsuan Chen, Gabriel K. Griffin, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
Journal: Blood
Blood (2019) 134 (23): 2059–2069.
DOI: https://doi.org/10.1182/blood.2019002206
Published: 2019
Includes: Supplemental data
Journal Articles

A Phase 2 Study of Retreatment with Brentuximab Vedotin in Patients with cHL, sALCL or Other CD30-Expressing PTCL

Sairah Ahmed, MD, Julie Lisano, PharmD, Trevor Newhook, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4054.
DOI: https://doi.org/10.1182/blood-2019-121523
Published: 2019
Journal Articles

Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study

Nancy L. Bartlett, MD, David J. Straus, MD, Monika Dlugosz-Danecka, MD PhD, Sergey Alekseev, PhD, Arpad Illes, MD, Ewa Lech-Maranda, MD PhD, Tatyana A. Feldman, MD, Piotr Smolewski, MD PhD, Kerry J Savage, BSc, MD MSc, Jan Walewski, MD PhD, Radhakrishnan Ramchandren, MD, Pier Luigi Zinzani, MD PhD, Martin Hutchings, MD PhD, Joseph M. Connors, MD, John Radford, Javier Munoz, MD MS, FACP, Won-Seog Kim, MD PhD, Ranjana H Advani, MD, Stephen M Ansell, MD PhD, Anas Younes, MD, Andrea Gallamini, MD, Harry Miao, MD, Rachael Liu, PhD, Keenan Fenton, Andres Forero-Torres, MD, Marco Picardi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4026.
DOI: https://doi.org/10.1182/blood-2019-124116
Published: 2019
Journal Articles

Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis

Victor M. Orellana-Noia, MD, Krista Isaac, DO,MS, Nolan A Wages, PhD, Mary-Kate Malecek, MD, Nancy L. Bartlett, MD, Timothy J Voorhees, MD, Natalie S Grover, MD, Steven R. Hwang, MD, N. Nora Bennani, MD, Rachel Hu, MD, Brian T. Hill, MD, Eric Mou, MD, Ranjana H Advani, MD, Jordan Carter, MD, Kevin A. David, MD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Gabriela Magarelli, APN, Tatyana A. Feldman, MD, Michael C. Churnetski, Jonathon B. Cohen, MDMS, Andrew M. Evens, DO, MSc, Craig A. Portell, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4027.
DOI: https://doi.org/10.1182/blood-2019-123572
Published: 2019
Journal Articles

Utilization of Immune Checkpoint Inhibitors for Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) in Oncology Community Practices

Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Chadi Nabhan, MDMBA, FACP, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 4057.
DOI: https://doi.org/10.1182/blood-2019-129632
Published: 2019
Journal Articles

Impact of Post-Transplant Consolidative Radiotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma and a PET-CT Based Predictive Model for Relapse

Collin Chin, MBBS, Andrew Wirth, MBBS, MD FRACP, FRANZCR, David Ritchie, MD PhD, Michael Hofman, MBBS (Hons), FRACP, FAANMS, Michael MacManus, John F. Seymour, MBBS, PhD FRACP, Belinda Campbell, MBBS, MMed, FRANZCR, Michael Dickinson, MBBS,FRACP,FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 4044.
DOI: https://doi.org/10.1182/blood-2019-122716
Published: 2019
Journal Articles

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Locke J. Bryan, MD, Scott E. Smith, MD PhD, Pamela Allen, MDMSc, Carla Casulo, Brett Alan Palmer, BS, Reem Karmali, MD, Barbara Pro, MD, Denise M Scholtens, PhD, Hatice Savas, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jane N. Winter, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4029.
DOI: https://doi.org/10.1182/blood-2019-123879
Published: 2019
Journal Articles

Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Study of the Latin America Working Group for Lymphomas (GELL)

Luis E Malpica Castillo, MD, Camila Peña, MD, Christine Rojas, MD, Pilar León, MD, Brady E. Beltrán, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Mimsy Quinones, MD, Sally Rose Paredes, MD, Henry Idrobo, MD, Ivan Perdomo, MD, Virginia Abello, MD, Lorena Fiad, MD, Victoria Otero, MD, Marialejandra Torres Viera, MD, Luis Villela M, Eduardo Sotomayor, MD, Jorge J Castillo, MD, Juan Carlos Ramos, MD BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4045.
DOI: https://doi.org/10.1182/blood-2019-122976
Published: 2019
Journal Articles

Outcomes of First-Line Treatment (FL) of Classical Hodgkin Lymphoma (cHL) in Argentina: A Real Life Multicenter Retrospective Study

Victoria Otero, MD, Carolina Valeria Mahuad, MD PhD, Laura Korin, MD, Enriqueta Martinez, MD, Fernando Warley, MSc, MD, Hernán García Rivello, Nancy Cristaldo, MD, Dana Kohan, Marta Zerga, MD, Gonzalo Martin Garate, MD, Maria De Los Angeles Vicente Reparaz, Maria Florencia Aizpurua, MD, Erica Rojas Bilbao, Susana Cerana, Maria Eugenia Funes, Iliana Plaza, Maria Cecilia Foncuberta, MD, Anahí Vijnovich Baron, MD, Santiago Cranco, MD, Adriana Vitriu, MD, Mariela Gomez, Justina Lavalle, Claudia Casali, MD, Manuela Clavijo, Luciana Melillo, MD, Maria Cecilia Cabral Lorenzo, Augusto Miroli, MD PhD, Laura Fishman, Maximiliano J. Pavlove, MD PhD, Marcela Miodosky, Silvana Cugliari
Journal: Blood
Blood (2019) 134 (Supplement_1): 4046.
DOI: https://doi.org/10.1182/blood-2019-126314
Published: 2019
Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Denisse A. Castro, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Christine Rojas, MD, Ivan Perdomo, MD, Pilar León, MD, Karen Lalupu, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, David Gomez-Almaguer, MD, Jose A Hernández-Hernández, PhD, Myrna Candelaria, MDPharmD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Andrés Gómez-De León, MD, Efreen Montaño Figueroa, PhD, Melani Otañez, MD, Carlos Best, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4121.
DOI: https://doi.org/10.1182/blood-2019-127479
Published: 2019
Journal Articles

A Complicated Neighborhood: Insights into the Hodgkin Lymphoma Microenvironment

Maher K. Gandhi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): SCI-8.
DOI: https://doi.org/10.1182/blood-2019-121284
Published: 2019
Journal Articles

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Martina Di Trani, Ettore Rizzo, Silvia Locatelli, PhD, Fabrizio Marino, MD, Vanessa Cristaldi, PhD, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Federica De Paoli, PhD, Giuseppa Careddu, Marcello Rodari, MD, Margarita Kirienko, MD, Eleonora Calabretta, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesca Ricci, MD, Arturo Chiti, MD, Armando Santoro, Stefan Hohaus, MD, Davide Rossi, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 131.
DOI: https://doi.org/10.1182/blood-2019-131096
Published: 2019
Journal Articles

May Tigit (T cell Ig and ITIM domain) Expression be a New Target for Hodgkin Lymphoma?

Ombretta Annibali, Antonella Bianchi, Alba Grifoni, Valeria Tomarchio, Mariantonietta Tafuri, MD, Martina Verri, Giuseppe Avvisati, MD, Anna Crescenzi
Journal: Blood
Blood (2019) 134 (Supplement_1): 5235.
DOI: https://doi.org/10.1182/blood-2019-130794
Published: 2019
Journal Articles

Expression of the Fractalkine Receptor (CX3CR1) Is Significantly Increased in Immune Cells of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma patients with Active Disease

Marzia Palma, MD PhD, Tom A. Mulder, MD, Kia Heimersson, Li-Sophie Rathje, PhD, Thomas Olin, MSc,PhD, Johan Schultz, MSc,PhD, Håkan Mellstedt, MD PhD, Anders Österborg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5445.
DOI: https://doi.org/10.1182/blood-2019-121818
Published: 2019
Journal Articles

Brentuximab Vedotin As Consolidation Therapy Post Hematopoietic Stem Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma: A Real World Analysis of the Colombian Experience

Bonell Patiño, MD, Cristina Acon-Solano, MD, Mario Pereira, MD, Leonardo Enciso-Olivera, MD, Diana Otero-de la Hoz, MD, Humberto Martínez Cordero, MD, Paola Spirko, MD, Julio Solano-Vega, MD, Mónica Arévalo-Zambrano, MD, Ulrike Heider, MD, Alejandro Ruiz-Patiño, MD, Claudia Lucia Sossa, MD, Angela María Peña, MD, Claudia Marcela Chalela, MD, Amado Karduss, MD, Guillermo León-Basantes, MD, Virginia Abello, MD, Daniel Lorenzo Espinosa, MD, Paola Guerrero, MD, Alvaro Guerrero, MD, Juan Manuel Herrera, MD, Monica Osuna, MD, Ivan Perdomo, MD, Carmen Rosales, MD, Paola Omaña, MD, Natalia Villarroya, MD, Víctor Rodriguez-Sanjuan, MD, Jose Sandoval-Sus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5275.
DOI: https://doi.org/10.1182/blood-2019-129295
Published: 2019